Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-04 | 2024-12-02+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $52.37 | -95.9K | 92.5K | -51% | -$5.02M |
| DM | 2024-12-04 | 2024-12-02+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $49.07 | +95.9K | 176.0K | +120% | +$4.71M |
| DM | 2024-12-04 | 2024-12-02+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $0.00 | -95.9K | 83.6K | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-03 | S | D | 6,315 | $53.14 | 93,794 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to 53.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-12-03 | S | D | 1,405 | $54.05 | 92,389 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.025 to $54.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-12-03 | M | A | 1,988 | $33.02 | 94,377 | D | — | — | |
| 4 | Common | Common Stock | 2024-12-03 | S | D | 600 | $53.04 | 92,389 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-12-03 | M | A | 600 | $33.02 | 92,989 | D | — | — | |
| 6 | Common | Common Stock | 2024-12-02 | S | D | 83,640 | $52.26 | 92,389 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.00 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2024-12-03 | M | A | 7,720 | $33.02 | 100,109 | D | — | — | |
| 8 | Common | Common Stock | 2024-12-02 | S | D | 1,960 | $52.17 | 92,389 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.00 to $52.83 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2024-12-02 | M | A | 1,960 | $51.00 | 94,349 | D | — | — | |
| 10 | Common | Common Stock | 2024-12-03 | S | D | 88 | $54.14 | 92,389 | D | — | — | |
| 11 | Common | Common Stock | 2024-12-03 | S | D | 1,900 | $53.13 | 92,477 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 12 | Common | Common Stock | 2024-12-02 | M | A | 83,640 | $51.00 | 176,029 | D | — | — | |
| 13 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 7,720 | $0.00 | 61,110 | D | $33.02 · — to 2029-01-02 | 7,720 Common Stock | (F8) Currently exercisable. |
| 14 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 1,988 | $0.00 | 15,512 | D | $33.02 · — to 2029-01-02 | 1,988 Common Stock | (F8) Currently exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 600 | $0.00 | 3,070 | D | $33.02 · — to 2029-01-02 | 600 Common Stock | (F8) Currently exercisable. |
| 16 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 83,640 | $0.00 | 0 | D | $51.00 · — to 2025-01-02 | 83,640 Common Stock | (F8) Currently exercisable. |
| 17 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 1,960 | $0.00 | 83,640 | D | $51.00 · — to 2025-01-02 | 1,960 Common Stock | (F8) Currently exercisable. |